Vanguard Fiduciary Trust
RVPH

Vanguard Fiduciary Trust’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Vanguard Fiduciary Trust’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,598
Closed -$23.1K – 4137
2026
Q1 		$23.1K Buy
+31,598
New +$144K ﹤0.01% 3932

Other funds holding RVPH

ECM
EMC Capital Management Houston, Texas $253M AUM
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PUI
Purpose Unlimited Inc Toronto $2.62B AUM
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
MWM
Mosley Wealth Management Anaheim, California $314M AUM

Vanguard Fiduciary Trust's RVPH Position: Q2 2026 in Review

Vanguard Fiduciary Trust sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 31,598 shares — an estimated $23.1K sold.

Vanguard Fiduciary Trust first reported a position in RVPH in Q1 2026 and held it in 1 quarter. The position peaked at $23.1K in Q1 2026. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

  • Vanguard Fiduciary Trust reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
  • Vanguard Fiduciary Trust sold 31,598 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $23.1K.
  • Vanguard Fiduciary Trust first reported a position in REVIVA PHARMA HLDGS INC in Q1 2026 and held it in 1 quarter.
  • Vanguard Fiduciary Trust's REVIVA PHARMA HLDGS INC position peaked at $23.1K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.